Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.


Latest Press Releases

Jaguar Health Completes Effectiveness Trial to Support FDA Approved Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
Healthcare & PharmaceuticalCompany Update

Jaguar Health Completes Effectiveness Trial to Support FDA Approved Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs

April 8, 2026 8:30 AM

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") today announced that the Company has completed the company's ongoing effectiveness study of crofelemer delayed-release tablets for the treatment of chemotherapy-induced diarrhea (CID) in dogs. Crofelemer, under the name Canalevia-CA1, is currently conditionally approved for the sole indication of treating CID in dogs. The approval for Canalevia CA-1 will expire on December 21, 2026. "We're very...

Read more
Wiley's 'The Black Book of Reshoring' by Douglas Brown Debuts at No. 3 on Amazon's Business Bestsellers List
Healthcare & PharmaceuticalCompany Update

Wiley's 'The Black Book of Reshoring' by Douglas Brown Debuts at No. 3 on Amazon's Business Bestsellers List

April 8, 2026 8:00 AM

Black Book Insights, a reshoring and manufacturing advisory and think tank, today announced that The Black Book of Reshoring: The Essential Guide to America's New Manufacturing Boom by founder Douglas Brown debuted at No. 3 on Amazon's Business Development Bestsellers List this past week. Published by Wiley on March 31, 2026, the book enters the market at a pivotal time for manufacturers, investors, policymakers, and economic development...

Read more
Envision Pharma Group appoints Nick Jones as President, Envision Medical Communications
Healthcare & PharmaceuticalCompany Update

Envision Pharma Group appoints Nick Jones as President, Envision Medical Communications

April 8, 2026 8:00 AM

Envision Pharma Group (Envision), a global, technology-enabled solutions partner to the life sciences industry, today announced the appointment of Nick Jones as President, Envision Medical Communications (EMC). In this role, Jones will lead the EMC business, focusing on integrating Envision's industry-leading technology and AI capabilities into its award-winning portfolio of solutions and services. Jones joins the company from ConcertAI, where...

Read more
Marijuana Rescheduling Countdown: Why the
Healthcare & PharmaceuticalCompany Update

Marijuana Rescheduling Countdown: Why the "Order of Operations" and Todd Blanche's Appointment Define the Path to Schedule III

April 8, 2026 6:30 AM

The transition of marijuana to Schedule III has entered its most critical phase: the final administrative "order of operations." Following President Donald J. Trump's historic December executive order and recent directives to Acting Attorney General Todd Blanche, the focus has shifted to the rigorous legal execution required to finalize the rule. For MMJ International Holdings, a leader in the FDA botanical drug development pathway, the current...

Read more
Rad Source Technologies Activates a Wealth of Peer-Reviewed Data with Bioz Badges to Strengthen Customer Use-Case Visibility
Healthcare & PharmaceuticalPartnerships

Rad Source Technologies Activates a Wealth of Peer-Reviewed Data with Bioz Badges to Strengthen Customer Use-Case Visibility

April 8, 2026 4:00 AM

Bioz, Inc., the leading scientific citation intelligence platform that transforms publications into measurable product validation and commercial impact, announced its collaboration with Rad Source Technologies, a global provider of advanced X-ray irradiation solutions for research and industrial applications. By embedding Bioz Badges across its product webpages, Rad Source is now surfacing peer-reviewed scientific validation to strengthen...

Read more
AlzeCure Pharma Publishes its Annual Report for 2025
Healthcare & PharmaceuticalEarnings

AlzeCure Pharma Publishes its Annual Report for 2025

April 8, 2026 2:15 AM

AlzeCure Pharma AB (publ) (STO:ALZCUR)(FRA:AC6), a biotech company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced that its Annual Report for 2025 has been published. "2025 was an active and positive year for AlzeCure Pharma. One of our main focus areas was to prepare the phase II study in Alzheimer's patients with NeuroRestore ACD856, for which we were awarded a...

Read more
Onco-Innovations Executes Engagement Agreement with RDI Partners and Establishes Onco-Innovations AU Pty. Ltd. to Advance Australian Phase I Strategy
Healthcare & PharmaceuticalCompany Update

Onco-Innovations Executes Engagement Agreement with RDI Partners and Establishes Onco-Innovations AU Pty. Ltd. to Advance Australian Phase I Strategy

April 7, 2026 6:00 PM

Onco-Innovations Limited (CBOECA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H) (WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce the execution of an engagement agreement with Research & Development Incentives Partners ("RDI Partners"), and the formation of Onco-Innovations AU Pty. Ltd. ("ONCO AU") as a wholly owned Australian subsidiary of the Company. Through the engagement with RDI Partners and the formation of its Australian subsidiary,...

Read more
MEDVi Under Fire: The $1.8 Billion AI Story, the FDA Warning Letter, and Why the QUAD Men's Health Program Wasn't Part of Any of It
Healthcare & PharmaceuticalAdvertorial

MEDVi Under Fire: The $1.8 Billion AI Story, the FDA Warning Letter, and Why the QUAD Men's Health Program Wasn't Part of Any of It

April 7, 2026 5:35 PM

This article is for informational purposes only and does not constitute medical advice. MEDVi QUAD is a compounded prescription medication requiring evaluation by a licensed clinician. Compounded medications are not FDA-approved as finished products. Prescription approval is not guaranteed. This article contains affiliate links - if a purchase is made through these links, a commission may be earned at no additional cost to you. This does not...

Read more
Queue Ventures Announces Mailing of Management Information Circular
Healthcare & PharmaceuticalCompany Update

Queue Ventures Announces Mailing of Management Information Circular

April 7, 2026 3:10 PM

Queue Ventures Ltd. ("Queue" or the "Company") is pleased to announce that the Company has mailed its management information circular dated March 30, 2026 (the "Circular") and related proxy materials in connection with its proposed statutory plan of arrangement (the "Arrangement") with Custom Health, Inc. ("Custom Health"), previously announced on May 30, 2025. The annual general and special meeting of Queue shareholders to vote on the...

Read more
HeyDonto AI Technology Closes $20 Million SEED Round at $200 Million Valuation to Scale Conduit - The Dental Interoperability Exchange
Healthcare & PharmaceuticalCompany Update

HeyDonto AI Technology Closes $20 Million SEED Round at $200 Million Valuation to Scale Conduit - The Dental Interoperability Exchange

April 7, 2026 1:20 PM

HeyDonto AI Technology (VMC MAR COM Inc. DBA HeyDonto) today announced the close of a $20 million SEED funding round at a $200 million valuation. The investment will fuel the scale-up of Conduit, the company's dental interoperability exchange platform, and position HeyDonto to lead the integration of dental data into the broader healthcare ecosystem. The round was led by eight leading private investors who are practicing dentists and dental...

Read more
Most Men Wait Years to See a Specialist - At Starke Medical Group, They Can Reach One Right Now
Healthcare & PharmaceuticalCompany Update

Most Men Wait Years to See a Specialist - At Starke Medical Group, They Can Reach One Right Now

April 7, 2026 1:00 PM

For most people dealing with a health concern - whether it's low testosterone, hormonal imbalance, a fitness plateau, or something they've been too embarrassed to bring up at all - the path to specialist care follows a familiar and frustrating script: wait weeks for an appointment, spend eight minutes with a physician who's never met them before, leave with a prescription and more questions than answers, and start the whole cycle over again. Dr....

Read more
Payer-to-Payer API Reality Gap Report Finds Most Exchanged Data Still Fails at the Point of Operational Use
Healthcare & PharmaceuticalProduct Announcements

Payer-to-Payer API Reality Gap Report Finds Most Exchanged Data Still Fails at the Point of Operational Use

April 7, 2026 12:11 PM

Black Book Research has released The Payer-to-Payer API Reality Gap: What Actually Makes Incoming Payer Data Unusable, a new Q2 2026 market analysis in its 2026 Black Book research series on payer IT, software, and services, examining why payer-to-payer interoperability continues to break down after the technical exchange succeeds. Based on Q2 2026 feedback from payer executives, operational leaders, and hands-on IT staff, the report finds that...

Read more
Recora Launches Aviary Health as It Expands Beyond Cardiac Recovery
Healthcare & PharmaceuticalCompany Update

Recora Launches Aviary Health as It Expands Beyond Cardiac Recovery

April 7, 2026 12:00 PM

Recora, Inc. today announced that its care services business will now operate under the brand Aviary Health, reflecting the company's expansion beyond virtual cardiac rehabilitation into a broader set of services for health systems. The move marks a natural next chapter for a company originally built around cardiac recovery and now positioned to help provider organizations launch and scale more complex clinical programs. Under the new brand,...

Read more
Respiratory Care Interstate Compact Reaches Milestone, Expanding RT Workforce Mobility
Healthcare & PharmaceuticalEnvironmental, Social and Governance

Respiratory Care Interstate Compact Reaches Milestone, Expanding RT Workforce Mobility

April 7, 2026 11:00 AM

The Respiratory Care Interstate Compact (RCIC) is official with the passage of the seventh and eighth states today. AARC, in collaboration with the Council of State Governments (CSG) and the Department of Defense (DoD), is proud to announce the formal launch of the RCIC, which now establishes the Respiratory Care Interstate Compact Commission. This initiative marks a new era for the respiratory therapy profession, streamlining licensure across...

Read more
Hope Matters Institute Nominated for Best Virtual Mental Health Company in Southern California
Healthcare & PharmaceuticalAwards

Hope Matters Institute Nominated for Best Virtual Mental Health Company in Southern California

April 7, 2026 10:00 AM

Hope Matters Institute has been nominated as the Best Virtual Mental Health Company in Southern California by the Santa Monica Daily Press. This distinction highlights the organization's dedication to accessible, compassionate, and personalized online therapy services for individuals and families across the state. Founded and led by Licensed Marriage and Family Therapist, Jennah Childs, the institute is founded on the belief that healing happens...

Read more
The Doctor Will See You Now: The Value of Human Connection in AI-Supported Medicine
Healthcare & PharmaceuticalEnvironmental, Social and Governance

The Doctor Will See You Now: The Value of Human Connection in AI-Supported Medicine

April 7, 2026 9:35 AM

Recently, a New York Times article explored the question of whether advancements to AI in medicine could reduce the value of a doctor. Do you see this taking place - or is AI redefining that value? Dr. Weinstein: I think AI changes the balance of how doctors work rather than reduces the value of that work. Technology has always shaped and reshaped medicine. The internet changed how we access information. Electronic health records changed how we...

Read more
CVS Health: Thank You! City Hall Place Grand Opening Kansas City, Kansas
Healthcare & PharmaceuticalEnvironmental, Social and Governance

CVS Health: Thank You! City Hall Place Grand Opening Kansas City, Kansas

April 7, 2026 9:00 AM

On March 12, 2026, CVS Health proudly celebrated the Grand Opening of City Hall Place in Kansas City, Kansas, alongside our valued colleagues, local leaders, community organizations, development partners, and residents. This event marked the opening of a new community that blends new construction with the adaptive reuse of the former Kansas City Hall, offering 104 thoughtfully designed affordable housing units for families earning up to 40% and...

Read more
Arthritis Foundation Invites the Public to Join Green Heart Fridays During Arthritis Awareness Month
Healthcare & PharmaceuticalCompany Update

Arthritis Foundation Invites the Public to Join Green Heart Fridays During Arthritis Awareness Month

April 7, 2026 9:00 AM

This May during Arthritis Awareness Month, the Arthritis Foundation is inviting people across the country to participate in Green Heart Fridays, a nationwide activation that encourages the public to share the Foundation's Green Heart, a growing national symbol of support for people living with arthritis. Throughout the month, artists in cities across the U.S. will share Green Heart-inspired artwork that sparks conversations and raises awareness...

Read more
Measles Rare Pediatric Disease Drug Designation Application Filed for NV-387, PRV Provides for Strong Business Case, Says NanoViricides
Healthcare & PharmaceuticalCompany Update

Measles Rare Pediatric Disease Drug Designation Application Filed for NV-387, PRV Provides for Strong Business Case, Says NanoViricides

April 7, 2026 8:30 AM

NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine technology that viruses cannot escape, announced today that it has filed an application for "Rare Pediatric Disease Drug" Designation (RPDD) for NV-387 as a Treatment for Measles with the US FDA Office of Orphan Products Development...

Read more
Jaguar Health Reports 2025 Financials
Healthcare & PharmaceuticalEarnings

Jaguar Health Reports 2025 Financials

April 7, 2026 8:30 AM

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today reported its consolidated fourth-quarter 2025 financial results. 2025 FOURTH QUARTER COMPANY FINANCIAL RESULTS: Net Revenue: The total net revenue for the Company's prescription products (Mytesi®, Gelclair®, and Canalevia®-CA1), non-prescription products, and license revenue was approximately $3.2 million in the fourth quarter of 2025, representing an increase of 5% over the...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers • July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie • July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers • July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers • June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers • June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers • June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?